Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-27 · accession 0000897069-25-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-29 | 2025-01-27 | PCSA | Young David | Pres. Research, Development, Dir | P - Purchase | $0.8 | +124.5K | 205.4K | +154% | +$99.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-27 | P | A | 124,500 | $0.8 | 205,405 | D | — | — |